Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126009073 | 12600907 | 3 | F | 20160822 | 20160728 | 20160901 | EXP | US-ROCHE-1798277 | ROCHE | , HELLMANN M, FIORE J, SMITH-MARRONE S, BASCH E, SCHWARTZ L, GINSBERG M, SHOUERY M, NEWMAN S, SHAW M, ROGAK L AND LASH A PHASE II STUDY OF A NON-PLATINUM-CONTAINING DOUBLET OF PACLITAXEL AND PEMETREXED WITH BEVACIZUMAB AS INITIAL THERAPY FOR PATIENTS WITH ADVANCED LUNG ADENOCARCINOMAS. JOURNAL OF THORACIC ONCOLOGY 2016 MAR 07;11 (6):890-899. | 0.00 | Y | 0.00000 | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126009073 | 12600907 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | ON DAYS 1 AND 15 | U | 125085 | 10 | MG/KG | |||||||
| 126009073 | 12600907 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | ON DAYS 1, 8 AND 15 | U | 0 | 90 | MG/M**2 | |||||||
| 126009073 | 12600907 | 3 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | ON DAYS 1 AND 15 | U | 0 | 500 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126009073 | 12600907 | 1 | Non-small cell lung cancer |
| 126009073 | 12600907 | 2 | Non-small cell lung cancer |
| 126009073 | 12600907 | 3 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126009073 | 12600907 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126009073 | 12600907 | Alanine aminotransferase increased | |
| 126009073 | 12600907 | Anaemia | |
| 126009073 | 12600907 | Aspartate aminotransferase increased | |
| 126009073 | 12600907 | Cough | |
| 126009073 | 12600907 | Decreased appetite | |
| 126009073 | 12600907 | Drug hypersensitivity | |
| 126009073 | 12600907 | Dysphonia | |
| 126009073 | 12600907 | Dyspnoea | |
| 126009073 | 12600907 | Fatigue | |
| 126009073 | 12600907 | Febrile neutropenia | |
| 126009073 | 12600907 | Hyperglycaemia | |
| 126009073 | 12600907 | Hypertension | |
| 126009073 | 12600907 | Lacrimation increased | |
| 126009073 | 12600907 | Leukopenia | |
| 126009073 | 12600907 | Liver function test increased | |
| 126009073 | 12600907 | Mucosal inflammation | |
| 126009073 | 12600907 | Myalgia | |
| 126009073 | 12600907 | Nausea | |
| 126009073 | 12600907 | Neutropenia | |
| 126009073 | 12600907 | Oedema | |
| 126009073 | 12600907 | Oedema peripheral | |
| 126009073 | 12600907 | Pain | |
| 126009073 | 12600907 | Pleural effusion | |
| 126009073 | 12600907 | Pneumonitis | |
| 126009073 | 12600907 | Small intestinal perforation | |
| 126009073 | 12600907 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |